Candriam SCA’s iShares US Medical Devices ETF IHI Stock Holding History

Candriam SCA’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,140	Closed	-$260K	–	830
2021 Q3	$260K	Hold	4,140	–	–	﹤0.01%	815
2021 Q2	$249K	Hold	4,140	–	–	﹤0.01%	828
2021 Q1	$216K	Hold	4,140	–	–	﹤0.01%	754
2020 Q4	$225K	Buy	+4,140	New	+$216K	﹤0.01%	767

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Candriam SCA's IHI Position: Q4 2021 in Review

Candriam SCA sold out of iShares US Medical Devices ETF (IHI) in Q4 2021, closing a stake of 4,140 shares — an estimated $260K sold.

Candriam SCA first reported a position in IHI in Q4 2020 and held it in 4 quarters. The position peaked at $260K in Q3 2021. 662 funds tracked by Wall St. Rank hold IHI as of Q4 2021.

Candriam SCA reported no remaining iShares US Medical Devices ETF position as of Q4 2021 after selling out during the quarter.
Candriam SCA sold 4,140 iShares US Medical Devices ETF shares in Q4 2021, an estimated $260K.
Candriam SCA first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 4 quarters.
Candriam SCA's iShares US Medical Devices ETF position peaked at $260K in Q3 2021.
662 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2021.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.